Inter-assay and Instrument Variability of Anti-Xa – Results

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Thromb Haemost 2000; 84(01): 138
DOI: 10.1055/s-0037-1613982

Letters to the Editor

Schattauer GmbH

Michael J. Kovacs

¹From the London Health Sciences Centre, University of Western Ontario, Canada

,

Michael Keeney

²Special Hematology/Flow Cytometry, London Health Sciences Centre, Ontario, Canada

Further Information

Received 03 November 1999

Accepted 15 February 2000

Publication Date:
10 December 2017 (online)

References
1 Kitchen S, Iampietro R, Woolley AM, Preston FE. Anti-Xa monitoring during treatment with low molecular weight heparin or danaparoid: Interassay variability. Thromb Haemost 1999; 82: 1289-93.

Article in Thieme Connect PubMed Google Scholar
2 Kovacs MJ, Keeney M, Weir K, MacKinnon K. A comparison of three methods of measuring low molecular weight heparin activity after total knee or hip arthroplasty. Lab Hemat 1996; 02: 111-4.

PubMed Google Scholar
3 Kovacs MJ, Keeney M, MacKinnon K, Boyle E. Three different chromogenic methods do not give equivalent anti-Xa levels for patients on therapeutic low molecular weight heparin (dalteparin) or unfractionated heparin. Clin Lab Haem 1999; 32: 55-60.

PubMed Google Scholar